Associations between clot burden measured by refined modified Miller score and cardiac biomarkers in patients with intermediate-high risk pulmonary embolism.
The rMMS reflects right ventricular strain in PE but does not appear suitable for prognostic risk stratification or guiding management decisions.
Abstract
BackgroundComputed tomography pulmonary angiography (CTPA) is essential for diagnosing pulmonary embolism (PE); however, the clinical and prognostic relevance of clot burden remains uncertain.PurposeTo evaluate the clinical significance and prognostic value of the refined Modified Miller Score (rMMS) in patients with intermediate- to high-risk PE.Material and MethodsIn total, 204 patients with intermediate- to high-risk PE who underwent baseline CTPA were included. Data on demographics, comorbidities, and biomarkers (troponin I/T, lactate, and D-dimer) were collected at admission. Patients were stratified by rMMS quartiles (Q1-Q4). Trends were analyzed using Cochran-Armitage and Jonckheere-Terpstra tests, while associations were assessed using Pearson's correlation and multivariable logistic regression.ResultsBaseline characteristics were comparable across quartiles. Higher rMMS was associated with alcohol use and prior arrhythmia. Increasing rMMS correlated with higher right ventricle:left ventricle ratio, increased heart rate, lower systolic blood pressure, and greater oxygen requirement. Weak correlations were observed between rMMS and lactate and troponin T, whereas no significant associations were found with troponin I or D-dimer. Crucially, rMMS was not associated with in-hospital outcomes or 1-year mortality.ConclusionThe rMMS reflects right ventricular strain in PE but does not appear suitable for prognostic risk stratification or guiding management decisions.
Background: Coronary artery disease remains a major contributor to morbidity and mortality worldwide. Simple and accessible tools for estimating coronary angiographic disease burden may facilitate risk stratification, particularly in settings with limited resources.
Objective: To develop and temporally internally valid...
K. Zenjaya, Kezia Rachel Priscilla, M. Angela et al.· Heart Science Journal· 0 citations
Background/Objectives: Lipid-derived and lymphocyte-based inflammatory indices (LBIIs) are studied in coronary artery disease (CAD), but their relationship with angiographic burden in patients aged ≤45 years with non-ST-elevation myocardial infarction (NSTEMI) remains unclear. We evaluated clinical, laboratory, lipid-d...
Şükriye Uslu, G. M. Yılmaz Öztekin, Muhammed Rıdvan Ersoysal et al.· Journal of Clinical Medicine· 0 citations
Pulmonary embolism (PE) is a potentially fatal cardiopulmonary emergency with unpredictable outcomes. Accurate risk stratification is critical for guiding intensive care unit (ICU) admission, optimizing resources, and improving prognosis. Clinical scores such as Pulmonary Embolism Severity Index (PESI), simplified PESI...
Elif Torun Parmaksız, Eylem Tunçay, N. Koçak et al.· Egyptian Journal of Bronchol...· 0 citations
Risk stratification in acute pulmonary embolism (PE) is crucial to guide therapeutic decisions. The shock index (SI), calculated as heart rate divided by systolic blood pressure, is a readily available haemodynamic marker, but its discriminatory ability as an isolated predictor is limited. Lactate, a marker of ti...
G. Marti, P. Fraile, C. Ferrera et al.· European Heart Journal· 0 citations
Among patients with symptomatic aortic stenosis undergoing TAVI, lower eGFRcys/eGFRcr and Cr * eGFRcys were associated with a higher risk of all-cause mortality after the procedure and Cr * eGFRcys showed stronger prognostic value and may provide additional prognostic information for risk stratification in patients und...
Yu Wang, Gui-Peng An, Xiang-Juan Liu et al.· Frontiers in Nutrition· 0 citations
High-sensitivity cardiac troponins are the gold-standard biomarkers for diagnosing myocardial injury. We have previously shown that elevated high-sensitivity troponin-T (hsTnT) is associated with both short- and long-term mortality in patients with acute pulmonary embolism (PE). However, it is unknown whether hsT...
C. Byrne, M. Afzal, J. Frary et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.